Pharmaceutical preparations for treating the onset and progression of oxidative stress in age-related diseases, namely, dry eye disease, glaucoma, cataract, macular degeneration (AMD), retinal degenerations, neurodegenerative disorders, noise and sonic blast induced hearing loss, and traumatic neural tissue injury; pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations for the treatment of hearing loss

'age':14 'age-rel':13 'amd':25 'blast':33 'cataract':22 'condit':51 'degener':24,27 'diseas':16,20,49 'disord':29 'dri':18 'eye':19,48 'glaucoma':21 'hear':35,58 'induc':34 'injuri':41 'loss':36,59 'macular':23 'name':17 'neural':39 'neurodegen':28 'nois':30 'onset':6 'oxid':10 'pharmaceut':1,42,52 'prepar':2,43,53 'progress':8 'relat':15 'retin':26 'sonic':32 'stress':11 'tissu':40 'traumat':38 'treat':4 'treatment':46,56

MFRM

Owners

Goods & Services